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Introduction: Diabetic patients with foot ulcers often suffer impaired wound healing due to diabetic
neuropathy and blood ﬂow disturbances. Direct injection of human adipose-derived stem cells (hASCs)
effectively accelerates wound healing, although hASCs are relatively unstable.
Methods: We developed an optimized protocol to engineer hASC sheets using temperature-responsive
culture dishes to enhance the function and stability of transplanted cells used for regenerative medi-
cine. Here, we evaluated the efﬁcacy of hASC sheets for enhancing wound healing. For this purpose, we
used a xenogeneic model of obese type 2 diabetes, the Zucker Diabetic Fatty rat (ZDF rat), which displays
full-thickness skin defects. We isolated hASCs from ﬁve donors, created hASC sheets, and transplanted
the hASC sheets along with artiﬁcial skin into full-thickness, large skin defects (15-mm diameter) of ZDF
rats.
Results: The hASC sheets secreted angiogenic growth factors. Transplantation of the hASC sheets com-
bined with artiﬁcial skin increased blood vessel density and dermal thickness, thus accelerating wound
healing compared with that in the controls. Immunohistochemical analysis revealed signiﬁcantly more
frequent neovascularization in xenografted rats of the transplantation group, and the transplanted hASCs
were localized to the periphery of new blood vessels.
Conclusion: This xenograft model may contribute to the use of human cell tissue-based products (hCTPs)
and the identiﬁcation of factors produced by hCTPs that accelerate wound healing.
© 2017, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).cells; ZDF rats, Zucker Diabetic Fatty Rats; AA, L-ascorbic acid phodpahte magnesium salt; CFA, Colony-forming assay;
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The International Diabetes Federation reported that there were
400 million patients with diabetes worldwide in 2015 [1] and
approximately 15%e25% of these patients suffer from foot ulcers
[2]. Therefore, the number of patients with diabetes, including
those affected by foot ulcers, will increase. Moreover, 7%e20% of
patients with diabetic foot ulcers undergo amputation of their
lower extremities [3]. Thus, there is an urgent need to establish
effective therapies to treat diabetic foot ulcers.
Wound healing involves complex biological and molecular re-
sponses to tissue injury [4]. Under diabetic conditions, evidence
indicates that multiple factors such as prolonged inﬂammation,
decreased collagen synthesis, decreased growth factor secretion,
and impaired neovascularization delay wound healing [5]. Treat-
ment with artiﬁcial skin accelerates the synthesis of new connec-
tive tissue matrices and regenerates the dermis [6]. However, using
only artiﬁcial skin to treat relatively large wounds caused by dia-
betic foot ulcers is difﬁcult because of diabetic neuropathy and
impaired blood ﬂow.
Cell-based therapy using human adipose-derived stem cells
(hASCs) represents a new approach to enhance wound healing
[7,8]. However, cells in a single-cell suspension of hASCs migrate
from the injection site to the wound area through diffusion [9,10].
To decrease the rate of migration of hASCs into the wound, we
developed cell-sheet engineering using temperature-responsive
culture dishes coated with the temperature-responsive polymer
N-isopropylacrylamide. The grafted polymer layer allows cultured
cells to adhere at 37 C and spontaneously detach from the surface
at <32 C. The dish enables nonenzymatic, noninvasive harvesting
of the cells as a sheet [11].
Clinical studies using cell sheets made of stem cells indicate the
efﬁcacy of this technique for treating esophageal ulcerations [12],
periodontitis [13], corneal dysfunction [14], and myocardial
infarction [15]. We previously generated rat adipose-derived stem
cell (rASC) sheets and found that transplantation of the rASC sheet
increased blood vessel density and dermal thickness, which were
associatedwith acceleratedwound healing comparedwith controls
[16]. These results suggest that the rASC sheet combined with
artiﬁcial skin offers a new approach to treat diabetic foot ulcers. We
tried to create hASCs sheets under clinical settings. Moreover, the
protocol of creating hASC sheets has not been reported yet.
The aim of this study was to establish the optimum protocol for
creating hASC sheets and to evaluate their efﬁcacy for accelerating
wound healing. For this purpose, we employed the Zucker Diabetic
Fatty Rat (ZDF rat) with full-thickness skin defects to serve as a
xenogeneic model of type 2 diabetes.Table 1
Clinical characteristics of donors.
Number Donor 1 Dono
Age (years) 66 52
Sex F F
BMI (kg/m2) 21.1 26.5
Amount of adipose tissue (mg) 2102 3556
Fasting blood glucose (mmol/L) 5.4
Postprandial blood glucose (mmol/L) 6.3
HbA1c (%) 5.7 5.8
HbA1c (mmol/mol) 39 40
Creatinine (mmol/L) 63 59
LDL cholesterol (mmol/L) 3.7 5.4
HDL cholesterol (mmol/L) 1.9 1.5
Triglycerides (mmol/L) 1.17 1.552. Materials and methods
2.1. Animals
Male ZDF rats (ZDF-Leprfa/CrlCrlj) aged 16 weeks (Charles River
Laboratories Japan, Kanagawa, Japan) were used to establish a
wound-healing model of type 2 diabetes and obesity. The Animal
Welfare Committee of Tokyo Women's Medical University
approved the use of rats. We used only male rats in this study,
considering that estrogen modiﬁes wound healing [17].
2.2. Human subjects
This study was conducted according to the principles of the
Declaration of Helsinki. The Institutional Review Board of the Tokyo
Women's Medical University approved the collection of human
samples and all donors provided written informed consent. Adi-
pose tissues were present in samples of lower abdominal subcu-
taneous fat collected from ﬁve donors with cancer who underwent
breast augmentation after mastectomy. Clinical data for each pa-
tient are presented in Table 1.
2.3. Isolation and culture of hASCs
Adipose tissuewas digested using collagenase NB6 GMP (0.3 U/g
tissue; Serva Electrophoresis, Heidelberg, Germany), at 37 C for 1 h
[18], followed by centrifugation at 700  g for 5 min at 22 C. The
cells were added to a T75 ﬂask (Falcon) and allowed to adhere to the
surface. The ﬂask contained a-MEM with GlutaMAX (Life-
Technologies, Carlsbad, CA, USA), 10% FBS (Moregate Biotech,
Queensland, Australia), 0.1% gentamicin (MSD, Tokyo, Japan), and
0.05% amphotericin B (Bristol-Myers Squibb, Tokyo, Japan)] at 37 C
in an atmosphere containing 5% CO2 for 24 h (Passage 0). After three
washes with phosphate-buffered saline (PBS) (Life Technologies,
Grand Island, NY, USA), new fresh medium was added. The cells
were subcultured using 0.25% trypsin-ethylenediaminetetraacetic
acid (EDTA; Life Technologies) every 3 days until Passage 2 and
the cryopreserved using a CELL BANKER 1 (Nippon Zenyaku Kogyo,
Fukushima, Japan). The cells were stored at 80 C for at least 1
month (Fig. 1a).
2.4. Proliferation assay
The numbers of cells from ﬁve donors per hASC sheet were
counted using a hemocytometer at days 0, 3, 5, 7, 10, 14, and 17 after
seeding on each of three temperature-responsive culture dishes
(UPCell; CellSeed, Tokyo, Japan).r 2 Donor 3 Donor 4 Donor 5
57 42 46
F F F
24.3 23.8 19.3
3604 3416 3549
5.2 4.8 5.4
5.5 5.5 5.5
37 37 37
44 55 63
3.7 2.3 2.8
1.6 1.7 2
1.75 0.79 0.51
Fig. 1. Transplantation procedure was performed using an hASC sheet combined with an artiﬁcial skin that was used to cover a full-thickness skin wound of a ZDF rat. (a) hASCs
were isolated and seeded, and then cultured until Passage 2, and cryopreserved. (b) hASCs were thawed, cultured until Passage 4, and seeded at 1.0  105 cells per temperature-
responsive culture dish at 37 C for 7 days. (c) The hASC sheet was directly transplanted onto a 15-mm diameter full-thickness skin wound created on the backs of ZDF rats that were
covered by an artiﬁcial skin in the transplantation group (n ¼ 4). Only artiﬁcial skin was transplanted onto the wounds in the control group (n ¼ 4). B: bandage, AD: adhesive
dressing, E: epidermis, D: dermis.
M. Hamada et al. / Regenerative Therapy 6 (2017) 65e73 672.5. Colony-forming assay
After cryopreservation, the cells isolated from the 5 donors were
thawed and cultured in completemedium (a-MEMwith GlutaMAX,
20% FBS, 0.1% gentamicin, and 0.05% amphotericin B) at 37 C in an
atmosphere containing 5% CO2. Passage-4 cells were used for the
experiments. The cells (100 cells in a 60-cm2 dish) were seeded in
each of three dishes per donor and cultured in complete medium
for 7 days. The cells were stained with 0.5% crystal violet (Kanto
Chemical, Tokyo, Japan) in methanol for 5 min, washed twice with
distilled water, and the number of colonies was counted.Table 2
Fluorescein isothiocyanate (FITC) e conjugated antibodies used for ﬂow cytometry.
Target Catalog no. Isotype control Source
CD11b 555388 Mouse IgG BD Pharmingena
CD29 555443 Mouse IgG BD Pharmingena
CD31 555445 Mouse IgG BD Pharmingena
CD44 550989 Mouse IgG BD Pharmingena
CD45 555482 Mouse IgG BD Pharmingena
CD90 555595 Mouse IgG BD Pharmingena
a BD Pharmingen, Franklin Lakes, NJ, USA.2.6. Differentiation assays
Differentiation assays using the cells isolated from the 5 donors
were performed three times per donor as previously described [19].
For adipogenesis, the cells (100 cells added to a 60-cm2 dish) were
cultured in complete medium. On day 7, the mediumwas replaced
with adipogenic medium as follows: complete medium containing
0.5 mmol/L isobutyl-methyl xanthine (SigmaeAldrich, St. Louis,
MO, USA), 100 nmol/L dexamethasone (DEX) (Fuji Pharma, Tokyo,
Japan), and 50 mmol/L indomethacin (Wako Pure Chemical, Osaka,
Japan). After 21 days, the cells were ﬁxed with 4% para-
formaldehyde (PFA) for 1 h and stained with Oil Red-O solution
(Wako Pure Chemical). To induce osteogenesis, the cells (50 cells
added to a 60-cm2 dish) were cultured in complete medium for 7
days and the medium was then replaced with osteogenic medium
as follows: complete medium containing 10 mmol/L b-glycer-
ophosphate (SigmaeAldrich), 10 nmol/L DEX, and 82 mg/mL L-
ascorbic acid phosphate magnesium salt n-Hydrate (AA) (Wako).
After 21 days, the cells were stained with 1% alizarin red S solution,
and the number of stained colonies was counted. The Oil Red-O-
positive rate or the alizarin red S-positive rate was calculated by
dividing the number of each positive colonies by the number of CFA
(n ¼ 3).
To induce chondrogenesis, 250,000 cells were placed in a 15-mL
polypropylene tube (Becton Dickinson, Mountain View, CA, USA)and centrifuged at 450 g for 10min. The pellet was cultured for 21
days in chondrogenic medium as follows: high-glucose Dulbecco's
modiﬁed Eagle's medium (Invitrogen) containing 500 ng/mL bone
morphogenetic protein 2 (R&D Systems, Minneapolis, MN, USA),
10 ng/mL transforming growth factor b3 (R&D Systems), 100 nmol/
L DEX, 82 mg/ml AA, 40 mg/mL proline, 100 mg/mL pyruvate, and
50 mg/mL Insulin-Transferrin-Selenium (ITS) þ Premix (Becton
Dickinson). For immunohistochemical analysis, the pellets were
embedded in OCT compound (Sakura Finetek; Torrance, CA, USA),
cut into 5-mm-thick sections using a cryostat (Leica CM 1850;
FINETEC, Tokyo, Japan), and stained with 1% toluidine blue or 0.1%
safranin O.
2.7. Karyotype analysis
Fifty cells from each hASC culture (Donors 1e5) were analyzed
using G-banding (Nihon Gene Research Laboratories, Miyagi, Japan)
to determine their karyotypes.
2.8. Flow cytometry
Seven days after seeding, the hASC sheets from ﬁve donors were
digested with collagenase NB6 GMP and 0.25% trypsin-EDTA as
previously described [20]. The cells (1  106) were suspended in
100 mL of PBS containing 10 mg/mL of each speciﬁc antibody
(Table 2) and incubated for 30 min at 4 C. The cells were then
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cence was determined using a Gallious ﬂow cytometer (Beckman
Coulter, CA, USA) and analyzed using Gallious and Kaluza software
(Beckman Coulter).
2.9. Cytokine secretion by hASC sheets
Conditioned medium (Donors 1e5) was collected from each
culture on days 3, 5, 7, and 10 after seeding on temperature-
responsive culture dishes. Each sample was centrifuged at
300 g for 3 min at 4 C, and the supernatant was stored at80 C.
The levels of vascular endothelial growth factor (VEGF), insulin-like
growth factor-1 (IGF-1), keratinocyte growth factor (KGF), hepa-
tocyte growth factor (HGF), ﬁbroblast growth factor-2 (FGF-2),
platelet-derived growth factor-BB (PDGF-BB), and epidermal
growth factor (EGF) were determined using ELISA kits (R&D
Systems).
2.10. Generation of hASC sheets
One hASC (Donor 4) was chosen for the transplantation study
according to the results of in vitro experiments (Figs. 2 and 3). The
hASCs (1.0  105) were seeded in 35-mm diameter temperature-Fig. 2. Proliferation, self-renewal ability, and multilineage differentiation of hASCs. (a) Num
assays of hASCs of ﬁve donors. Crystal violet staining was performed for the CFA on day 7 and
Oil Red-O-positive colonies and alizarin red S-positive colonies was calculated (n ¼ 3). (d) T
blue or safranin O, respectively. Scale bar ¼ 100 mm.responsive culture dishes followed by culture in complete me-
dium. After 3 days, the medium was replaced with complete me-
dium containing 82 mg/mL AA and incubated for 4 days. The hASCs
were then cultured on temperature-responsive dishes incubated at
20 C in 5% CO2 atmosphere. The cells formed a contiguous cell
sheet and spontaneously detached (Fig. 1b).
2.11. Transplantation of hASC sheets onto full-thickness skin defects
in ZDF rats
Male ZDF rats (n ¼ 4) aged 16 weeks (weight range, 520e710 g)
were used for transplantation experiments. ZDF rats were anes-
thetized by inhalation of 4% isoﬂurane (Pﬁzer) and the skin was
shaved. The blood glucose levels of the ZDF rats were measured
using a blood glucose monitor (Glutest Neo Sensor; Sanwa Kagaku
Kenkyusho, Nagoya, Japan) and their body weights were measured
before surgery and after they were sacriﬁced. Next, two circular
full-thickness skin defects on the back were created using a 15-mm
diameter skin punch, 3-cm caudal to the intrascapular region, and
defects were separated by1 cm [21] (Fig. 1c). In the engrafted rats
(transplantation group, n ¼ 4 per group), one hASC sheet
(7  105 cells) was directly transplanted onto the defect and arti-
ﬁcial skin (Pelnac; Smith&Nephew, Tokyo, Japan) 15-mmdiameterber of hASCs per hASC sheet. (b) CFA and adipogenic and osteogenic differentiation
Oil Red-O and alizarin red S staining were performed on day 28 (n ¼ 3). (c) The ratio of
o evaluate chondrogenic differentiation, hASCs in a pellet were stained with toluidine
Fig. 3. Flow cytometric analysis of surface antigens expressed by hASCs. (a) hASCs expressed CD29, CD44, and CD90 but did not express detectable levels of CD11b, CD31, and CD45.
(b) The levels of human VEGF, HGF, FGF-2, IGF-1, EGF, PDGF-BB, and KGF were determined using quantitative ELISA kits. The values shown represent the mean ± SD.
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group), only the artiﬁcial skin covered on the defects. Next, a
15  15 mm nonadhesive dressing (Hydrosite plus; Smith &
Nephew) was placed on the artiﬁcial skin applied to the test and
control rats and then covered with bandages (Hilate; Iwatsuki,
Tokyo, Japan) to protect the wound and avoid dislocation (Fig. 1c).2.12. Measurement of wounds and wound-closure time
The wounds were observed every 3 days until they completely
closed. The wound-closure time was deﬁned as when the wound
was completely epithelialized. The wound area was quantiﬁed us-
ing ImageJ software (National Institutes of Health, Bethesda, MD,
USA) in each ZDF rat at each observation.2.13. Immunohistochemistry
Four ZDF rats in each group were sacriﬁced 14 days after trans-
plantation. Following ﬁxation with 4% PFA for 30 min at 4 C, the
wound tissues were washed with PBS and immersed in PBS con-
taining 30% sucrose at 4 C for 24 h. The wound tissues were
embedded in Tissue-Tek OCT compound (Sakura Finetek), snap-
frozen in liquid nitrogen, and cut into 14-mm thick sections using a
cryostat. The frozen sections were stained with hematoxylin and
eosin stain (HeE stain) for histological analysis and processed for
immunohistochemistry. The frozen sections were incubated in 4%
Block Ace (Dainippon Seiyaku, Osaka, Japan) to block nonspeciﬁc
immunoreactions and stained with primary antibodies in PBS con-
taining 1% bovine serum albumin (SigmaeAldrich) at 4 C overnight.
Used primary antibodies were as follows: Rabbit anti-human CD31(1:50; RB-10333-P, Thermo Fisher Scientiﬁc Anatomical Pathology,
Fremont, CA, USA) and mouse anti-human STEM121 (1:50; Y40410,
Takara Bio, Shiga, Japan). They were used to quantify vascularization
in the wound and detect the transplanted hASCs, respectively. After
three washes with PBS, specimens were incubated with a bio-
tinylated anti-rabbit antibody (1:200; 711-066-152, Jackson Immu-
noResearch, West Grove, PA, USA) and a Cy3-conjugated anti-mouse
secondary antibody (1:200; 715-166-151, Jackson ImmunoResearch)
for 3 h at room temperature. The biotinylated antibody was then
visualized by incubation with Alexa Fluor 488-conjugated strepta-
vidin (1:1000; 016-540-084, Jackson ImmunoResearch) for 1 h at
room temperature. HeE stained sections and sections reacted with
antibodies were examined using a Keyence BZ-9000 ﬂuorescence
microscope (Keyence Corp, Chicago, USA).2.14. Tissue measurements
Dermal thickness and the blood vessel densityweremeasured 14
days after transplantation. The dermal thicknesses of three randomly
selected points of H-E stained sections were measured. The relative
area of CD31-positive blood vessels (VA) was calculated as follows:
VA(%)¼VAact/Af100, (VAact, CD31-positive vessels; Af, areaof the
ﬁeld). The average of the six areas in the twowounds (three areas per
wound) of each ZDF rat was recorded as the blood vessel density.2.15. Statistical analysis
The data are expressed as the mean ± standard deviation (SD).
All samples were analyzed using the Student's t-test and p < 0.05
was considered signiﬁcant.
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3.1. Characterization of hASCs
The averages of the hASCs per sheet (n ¼ 5) were 1.0  105,
1.14  105, 5.14  105, 7.18  105, 10.5  105, 7.45  105, and
7.35  105 cells on days 0, 3, 5, 7, 10, 14, and 17, respectively. The
number of hASCs per sheet gradually increased until day 10
(Fig. 2a). The hASC sheet from Donor 3 shrank on day 10. The hASCs
formed colonies and differentiated along the pathways of adipo-
genesis, osteogenesis, and chondrogenesis (Fig. 2bee). Flow cyto-
metric analysis detected that CD29-, CD90-, and CD44-positive cells
occupied more than 90% of all hASCs, while CD11b-, CD31-, and
CD45-positive cells occupied less than 1% (Fig. 3a). These results are
consistent with the characteristics of hASCs that meet the standard
minimal criteria of the phenotype of mesenchymal stem cells
(MSCs) deﬁned by Dominici et al. [22].
3.2. hASCs secrete multiple growth factors
ELISA assays revealed that the hASCs secreted VEGF, IGF-1, KGF,
HGF, FGF, PDGF-BB, and EGF. The average of maximum time of
secretion of these cytokines was 7.29 ± 2.06 days after seeding
(Fig. 3b). Accordingly, cell sheets were harvested on day 7 for the
transplantation study.
3.3. Karyotype analysis
G-banding of hASCs (Donors 1e5) revealed that the number,
banding, and shape of the chromosomes of each hASC sample were
normal (Fig. 4).
3.4. Wound healing in vivo
The average wound areas on days 0, 3, 7, 10, 14, 17, 21, and 24
(n ¼ 4) after transplantation were 2.32 ± 0.20, 1.90 ± 0.33,
1.66 ± 0.39, 1.21 ± 0.50, 0.55 ± 0.38, 0.21 ± 0.14, 0.11 ± 0.10, and
0.07 ± 0.04 cm2 in the transplantation group, respectively, and
2.32 ± 0.23, 2.15 ± 0.26, 2.00 ± 0.25, 1.60 ± 0.34, 1.12 ± 0.35,
0.88 ± 0.25, 0.49 ± 0.17, and 0.30 ± 0.06 cm2 in the control group,Fig. 4. G-banding of hASCs (Donors 1e5) at Passage 4 after long-term (31e136 days) cryop
normal.respectively. Wound healing was signiﬁcantly accelerated in the
transplantation group compared with the control group from day 3
onward (Fig. 5a and b). The average complete wound closure time
was signiﬁcantly shorter in the transplantation group (24.75 ± 5.33
days) compared with that of the control group (47.25 ± 8.33 days)
(Fig. 5c). Clinical signs of immunorejection such as erythema,
inﬂammation, and necrosis were not observed in either group
during the experiment. The average blood glucose levels
(402.78 ± 120.19 mg/dL and 437.22 ± 90.06 mg/dL in the trans-
plantation and control groups, respectively) were not signiﬁcantly
different. The blood glucose levels of the groups were 300 mg/dL.3.5. Histological and immunohistochemical analyses
HeE-stained specimens 14 days after transplantation (Fig. 6a)
revealed that the dermal thickness of the transplantation group
(1.69 ± 0.72 mm) was signiﬁcantly higher compared with that of
the control group (1.10 ± 0.32 mm) (Fig. 6c). Immunohistochemical
analysis revealed the presence of CD31-positive blood vessels in
each group. Transplanted hASCs were detected only in the trans-
plantation group. Merged immunoﬂuorescence images demon-
strated that hASCs localized circumferentially in the CD31-positive
blood vessels (Fig. 6b). Lumen formation in the wound was often
observed in the transplantation group (Fig. 6b). The average CD31-
positive area was signiﬁcantly higher in the transplantation group
(6.60± 1.96%) compared with that of the control group
(3.15 ± 0.84%) (n ¼ 4) (Fig. 6d).4. Discussion
Direct injection of hASCs into wounds promotes healing [23,24],
although the hASCs are relatively unstable [9,10]. Considering the
potential problems of immunorejection, autologous hASCs are
considered the best source. However, isolation of autologous hASCs
from diabetic patients is not a good choice because preparation of
hASC sheets requires several weeks and exposes patients to risk of
adverse effects such as severe diabetic complications, laparotomy
dehiscence caused by impaired wound healing, and infection.
Therefore, we consider using allogenic rather than autologous
hASCs in future clinical trials. Moreover, in allogenicreservation revealed that the number, banding, and shape of the chromosomes were
Fig. 5. Wound closure with or without a transplanted hASC sheet. (a) Representative macroscopic images of the wounds in the transplantation and control groups (n ¼ 4 each).
Scale bars ¼ 1 cm. (b) The average wound area of the transplantation group was signiﬁcantly smaller compared with that of the control group, starting 3 days after transplantation.
*p < 0.05. (c) The average complete wound-closure time of the transplantation group was signiﬁcantly shorter compared with that of the control group. *p < 0.05. The values shown
represent the mean ± SD.
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several lots to improve treatment. Thus, MSC markers that serve to
assess the treatment effects are needed. However, suchmarkers are
not available. Therefore, we aimed to identify such markers to
improve treatment.
We collected human subcutaneous adipose from patients who
were undergoing mastectomy because liposuction procedures are
rarely performed in our hospital. Although these samples were
collected from patients with cancer, chromosomal tests and G-
banding did not detect genetic abnormalities. Moreover, there are
no phenotypic differences between hASCs isolated from patients
with cancer and those from healthy subjects such as self-renewal,
surface-marker expression, and ability to differentiate into
different cell lineages [25]. Previous studies of wound healing using
hASC sheets employed animal models with full-thickness skin de-
fects 10e12 mm in diameter that tend to heal well [21,26]. In
contrast, here we created large full-thickness skin defects (15-mm
in diameter) on the backs of ZDF rats. Given the size of the skin
defects and the animal models, this study focused on the effects of
hASC sheets on larger wounds compared with those used in pre-
vious studies [21,26]. Surprisingly, in the present study, xenogeneic
transplantation of hASC sheets enhanced wound healing in ZDF
rats. Moreover, the clinical signs of immunorejection such aserythema, inﬂammation, and necrosis [27,28] were not detected
here. Further studies are therefore required to determine whether
the hASC sheets suppress immunorejection.
Wound healing is a multifactorial process that involves
inﬂammation, reepithelialization, angiogenesis, extracellular ma-
trix deposition, and tissue remodeling [5], which requires growth
factors. ASCs were found to secrete angiogenic growth factors
in vitro and in vivo and not only contribute to cutaneous regener-
ation but also participate in new vessel formation [23]. Here, we
show that VEGF, KGF, FGF, IGF-1, HGF, PDGF-BB, and EGF were
secreted by hASCs into the conditioned medium. These growth
factors play important roles in angiogenesis and wound healing
[29,30]. The activities of growth factors are signiﬁcantly impaired in
patients with diabetes [5]; thus, we hypothesized that the secretion
of growth factors is important for estimating the efﬁcacy of hASCs
for further transplantation therapy. It is known that VEGF is the
most effective and speciﬁc growth factor that regulates angiogen-
esis [31,32]. Our previous study suggests that VEGF signaling
stimulated angiogenesis and wound healing [16,33]. Previous
studies reported that the high expression levels of angiogenic
growth factors increased the rate and degree of granulation tissue
and capillary formation and thus accelerated wound healing
[23,34,35]. In the present study, we selected Donor 4 for
Fig. 6. Histological analysis of wounds treated with or without hASC sheets. (a) Representative histological images of HeE-stained wounds on day 14 after transplantation. Scale
bars ¼ 500 mm. (b) The upper section is low-power ﬁeld photos. Scale bars ¼ 100 mm. The below section is high-power ﬁeld photos. Scale bars ¼ 50 mm. In the control group, only
CD31-positive areas (green) were observed. In the transplantation group, areas positive for STEM 121 (red) were detected along the periphery of the CD31-positive endothelial cells
(green). (c) Dermal thickness in the transplantation group was signiﬁcantly higher compared with that of the control group (n ¼ 4) on day 14. *p < 0.05. The values represent the
mean ± SD. (d) The upper section is low-power ﬁeld photos. Scale bars ¼ 100 mm. The below section is high-power ﬁeld photos. Scale bars ¼ 50 mm. The densities of blood vessels in
the wound area were measured on day 14 after transplantation and were calculated by dividing the area of CD31-positive vessels by the total area. Scale bars ¼ 50 mm *p < 0.05. The
values shown represent the mean ± SD.
M. Hamada et al. / Regenerative Therapy 6 (2017) 65e7372transplantation because the cells secreted growth factors and the
levels of VEGF were the highest among the samples.
The present study shows that the time required for complete
wound healing was signiﬁcantly shorter, blood vessel density was
signiﬁcantly higher, and dermal thickness was signiﬁcantly
increased in the transplantation group compared with those of the
control group. Thinner skin and reduced density of capillaries in the
dermal layer of patients with diabetes are common causes of
impaired wound healing that lead to lower-limb amputation [36].
Here, blood vessel density in the wound area was signiﬁcantly
higher and mature vessels with lumen formation were more
frequent in the transplantation group than in the control group.
These ﬁndings suggest that neovascularization was accelerated in
the transplantation group and the mechanism involved signaling
by growth factors secreted by the hASCs.
To summarize, the results of the present study suggest that the
hASCs accelerated wound healing by thickening the dermis and
neovascularizing the wound area. These ﬁndings led us to
conclude that we have established the optimum protocol for
generating hASC sheets that signiﬁcantly accelerate wound heal-
ing. Our experimental system using ZDF rats may serve as a
valuable model for evaluating the efﬁcacy of human cell tissue-
based products (hCTPs). Moreover, this model may contribute to
the veriﬁcation of the clinical efﬁcacy of hCTPs and the identiﬁ-
cation of factors produced by hCTPs that mediate their beneﬁcial
effects.5. Conclusions
We established an optimum protocol for generating hASC sheets
and a system to evaluate their effects using a rat xenograft model of
obese diabetes. Xenogeneic hASC sheet transplantation combined
with artiﬁcial skin accelerated the healing of large wounds through
promoting angiogenesis and the paracrine effects by secreted
growth factors.
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